Predict your next investment

Cygnal Therapeutics company logo
HEALTHCARE | Biotechnology
cygnaltx.com

See what CB Insights has to offer

Total Raised

$65M

Investors Count

1

Cygnal Therapeutics Funding, Cygnal Therapeutics Valuation & Cygnal Therapeutics Revenue

2 Fundings

Cygnal Therapeutics's latest funding round was a Series B for $65M on May 28, 2019.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/28/2019

Series B

$65M

$0.00B

((9.99x))

FY 1234

4

5/15/2017

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

5/28/2019

5/15/2017

Round

Series B

Series A

Amount

$65M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

4

10

Cygnal Therapeutics Investors

1 Investors

Cygnal Therapeutics has 1 investors. Flagship Pioneering invested in Cygnal Therapeutics's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/28/2019

5/28/2019

1
Series B

Venture Capital

Massachusetts

First funding

5/28/2019

Last Funding

5/28/2019

Investor

Rounds

1
Series B

Board Seats

Type

Venture Capital

Location

Massachusetts

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.